Literature DB >> 16434429

Health consequences of the first Persian Gulf War on French troops.

R Salamon1, C Verret, M A Jutand, M Bégassat, F Laoudj, F Conso, P Brochard.   

Abstract

Since 1993, many studies on the health of Persian Gulf War Veterans (PGWV) have been undertaken. These studies have concluded that there has been an increased mortality due to external causes, no excess of recognized diseases, and no effect on PGWV children. When compared with the non-deployed, PGWV have reported a higher frequency of infertility as well as different symptoms, but a specific Gulf War syndrome was not identified. In October 2000, the French government asked an independent working group to analyse the scientific literature on PGWV health. The group concluded that an exhaustive study of French PGWV was to be undertaken. The objectives of this study were to describe the exposures of PGWV in the operations theatre, to report on the symptoms and diseases that occurred in PGWV and their children during and after the military campaign, and to explore the possibility of a Gulf War syndrome. This exhaustive cross-sectional study, which included all civilians and troops who served in the Gulf from August 1990 to July 1991, began in January 2002. Data were collected by postal self-administered questionnaires. A standardized clinical evaluation was performed by 27 clinics of occupational diseases and nine military hospitals. Symptoms and diseases which appeared after the campaign are described. To date, among 20,261 PGWV, 5,666 participated in the study (28%). The most frequent symptoms described since the return from the Gulf were headaches (83%), neurological or psychological symptoms, and back pain. Apart from well-known symptoms associations (respiratory, neurocognitive, psychological and musculo-skeletal syndromes), no other cluster was highlighted by our analysis.

Entities:  

Mesh:

Year:  2006        PMID: 16434429     DOI: 10.1093/ije/dyi318

Source DB:  PubMed          Journal:  Int J Epidemiol        ISSN: 0300-5771            Impact factor:   7.196


  7 in total

1.  Aluminum adjuvant linked to Gulf War illness induces motor neuron death in mice.

Authors:  Michael S Petrik; Margaret C Wong; Rena C Tabata; Robert F Garry; Christopher A Shaw
Journal:  Neuromolecular Med       Date:  2007       Impact factor: 3.843

2.  Temporal relationships between Gulf War deployment and subsequent psychological disorders in Royal Australian Navy Gulf War veterans.

Authors:  Dean P McKenzie; Mark Creamer; Helen L Kelsall; Andrew B Forbes; Jillian F Ikin; Malcolm R Sim; Alexander C McFarlane
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2009-09-10       Impact factor: 4.328

Review 3.  Aluminum in the central nervous system (CNS): toxicity in humans and animals, vaccine adjuvants, and autoimmunity.

Authors:  C A Shaw; L Tomljenovic
Journal:  Immunol Res       Date:  2013-07       Impact factor: 2.829

4.  Multiple Mild Traumatic Brain Injuries Are Associated with Increased Rates of Health Symptoms and Gulf War Illness in a Cohort of 1990-1991 Gulf War Veterans.

Authors:  Megan K Yee; Patricia A Janulewicz; Daniel R Seichepine; Kimberly A Sullivan; Susan P Proctor; Maxine H Krengel
Journal:  Brain Sci       Date:  2017-07-09

5.  Meta-analysis of self-reported health symptoms in 1990-1991 Gulf War and Gulf War-era veterans.

Authors:  Alexis L Maule; Patricia A Janulewicz; Kimberly A Sullivan; Maxine H Krengel; Megan K Yee; Michael McClean; Roberta F White
Journal:  BMJ Open       Date:  2018-02-13       Impact factor: 2.692

6.  The long-term hospitalization experience following military service in the 1991 Gulf War among veterans remaining on active duty, 1994-2004.

Authors:  Tomoko I Hooper; Samar F Debakey; Barbara E Nagaraj; Kimberly S Bellis; Besa Smith; Tyler C Smith; Gary D Gackstetter
Journal:  BMC Public Health       Date:  2008-02-13       Impact factor: 3.295

7.  Reproductive health and pregnancy outcomes among French gulf war veterans.

Authors:  Catherine Verret; Mathe-Aline Jutand; Catherine De Vigan; Marion Bégassat; Lynda Bensefa-Colas; Patrick Brochard; Roger Salamon
Journal:  BMC Public Health       Date:  2008-04-28       Impact factor: 3.295

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.